Association of the G473A polymorphism and expression of lysyl oxidase with breast cancer risk and survival in European women: A hospital-based case-control study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Friesenhengst, Andrea ^a   Pribitzer Winner, Tamara ^a,b   Schreiber, Martin ^a,c  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b UNIVERSITY OF APPLIED SCIENCES   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE;

ADULT; ALLELE; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; ETHNIC GROUP; EUROPEAN; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS FREE SURVIVAL; ONSET AGE; POSTMENOPAUSE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; BREAST TUMOR; EUROPE; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-LYSINE 6-OXIDASE; RNA, MESSENGER;

EID: 84940237009     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105579     Document Type: Article

References (34)

1. Barker HE, Cox TR, Erler JT (2012) The rationale for targeting the LOX family in cancer. Nature reviews Cancer 12: 540-552.
2. Kagan HM, Li W (2003) Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. Journal of Cellular Biochemistry 88: 660-672. (Pubitemid 36258816)
3. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, et al. (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226.
4. Min C, Yu Z, Kirsch KH, Zhao Y, Vora SR, et al. (2009) A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer research 69: 6685-6693.
5. Kaneda A, Wakazono K, Tsukamoto T, Watanabe N, Yagi Y, et al. (2004) Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer research 64: 6410-6415. (Pubitemid 39297894)
6. Bouez C, Reynaud C, Noblesse E, Thepot A, Gleyzal C, et al. (2006) The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model. Clinical cancer research 12: 1463-1469.
7. Rost T, Pyritz V, Rathcke IO, Gorogh T, Dunne AA, et al. (2003) Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas. Anticancer research 23: 1565-1573. (Pubitemid 36754130)
8. Contente S, Kenyon K, Rimoldi D, Friedman RM (1990) Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249: 796-798.
9. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, et al. (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15: 35-44.
10. Min C, Kirsch KH, Zhao Y, Jeay S, Palamakumbura AH, et al. (2007) The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer research 67: 1105-1112.
11. Bais MV, Nugent MA, Stephens DN, Sume SS, Kirsch KH, et al. (2012) Recombinant Lysyl Oxidase Propeptide Protein Inhibits Growth and Promotes Apoptosis of Pre-Existing Murine Breast Cancer Xenografts. PloS one 7: e31188.
12. Palamakumbura AH, Jeay S, Guo Y, Pischon N, Sommer P, et al. (2004) The propeptide domain of lysyl oxidase induces phenotypic reversion of rastransformed cells. The Journal of biological chemistry 279: 40593-40600. (Pubitemid 39287651)
13. Liu Y, Lv B, He Z, Zhou Y, Han C, et al. (2012) Lysyl oxidase polymorphisms and susceptibility to osteosarcoma. PloS one 7: e41610.
14. Shi W, Yang B, Li X, Sun S, Wang L, et al. (2012) The effect of lysyl oxidase polymorphism on susceptibility and prognosis of nonsmall cell lung cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 33: 2379-2383.
15. Wang X, Cong JL, Qu LY, Jiang L, Wang Y (2012) Association between Lysyl Oxidase G473A Polymorphism and Ovarian Cancer in the Han Chinese Population. Journal of International Medical Research 40: 917-923.
16. Wu J, Cai C, Tong D, Hou H (2012) Lysyl oxidase G473A polymorphism is associated with increased risk of ovarian cancer. Genetic testing and molecular biomarkers 16: 915-919.
17. Yoon JH, Park JK, Kang YH, Park YK, Nam SW, et al. (2011) Lysyl oxidase G473A polymorphism is closely associated with susceptibility to gastric cancer in a South Korean population. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 119: 762-768.
18. Ren J, Wu X, He W, Shao J, Cheng B, et al. (2011) Lysyl oxidase 473 G>A polymorphism and breast cancer susceptibility in Chinese Han population. DNA and cell biology 30: 111-116.
19. Behmoaras J, Slove S, Seve S, Vranckx R, Sommer P, et al. (2008) Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta. Rejuvenation research 11: 883-889.
20. Kauppila S, Stenback F, Risteli J, Jukkola A, Risteli L (1998) Aberrant type I and type III collagen gene expression in human breast cancer in vivo. The Journal of pathology 186: 262-268. (Pubitemid 28494353)
21. Baker AM, Cox TR, Bird D, Lang G, Murray GI, et al. (2011) The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. Journal of the National Cancer Institute 103: 407-424.
22. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, et al. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 101: 811-816. (Pubitemid 38121040)
23. Kerjaschki D, Bago-Horvath Z, Rudas M, Sexl V, Schneckenleithner C, et al. (2011) Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. The Journal of Clinical Investigation 121: 2000-2012.
24. Sleeman JP, Christofori G, Fodde R, Collard JG, Berx G, et al. (2012) Concepts of metastasis in flux: the stromal progression model. Seminars in cancer biology 22: 174-186.
25. Spano D, Heck C, De Antonellis P, Christofori G, Zollo M (2012) Molecular networks that regulate cancer metastasis. Seminars in cancer biology 22: 234-249.
26. Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, et al. (2006) Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS medicine 3: e47.
27. Proestling K, Hebar A, Pruckner N, Marton E, Vinatzer U, et al. (2012) The Pro Allele of the p53 Codon 72 Polymorphism Is Associated with Decreased Intratumoral Expression of BAX and p21, and Increased Breast Cancer Risk. PLoS ONE 7: e47325.
28. Taubenschub E, Marton E, Mogg M, Frech B, Ehart L, et al. (2013) The L10P Polymorphism and Serum Levels of Transforming Growth Factor b1 in Human Breast Cancer. International Journal of Molecular Sciences 14: 15376-15385.
29. Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, et al. (2005) Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization. Clin Cancer Res 11: 8348-8357. (Pubitemid 41746947)
30. Pacher M, Seewald MJ, Mikula M, Oehler S, Mogg M, et al. (2007) Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells. Carcinogenesis 28: 49-59. (Pubitemid 44942626)
31. Stampfer MR, Bartley JC (1988) Human mammary epithelial cells in culture: differentiation and transformation. Cancer treatment and research 40: 1-24.
32. R Development Core Team (2009) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
33. Bender R, Lange S (2001) Adjusting for multiple testing-when and how? Journal of clinical epidemiology 54: 343-349.
34. Harrington DP, Fleming TR (1982) A Class of Rank Test Procedures for Censored Survival-Data. Biometrika 69: 553-566.